LUIS
GUTIÉRREZ ROJAS
PROFESOR CONTRATADO DOCTOR
Centro de Investigacion Biomedica en Red de Salud Mental
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (14)
2023
-
Current Opinions about the Use of Duloxetine: Results from a Survey Aimed at Psychiatrists
Brain Sciences, Vol. 13, Núm. 2
-
Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review
European Child and Adolescent Psychiatry
2022
-
Endocrine biomarkers related to sleep-wake cycle and sleep disturbances in patients with bipolar disorder: A systematic review
European Journal of Psychiatry, Vol. 36, Núm. 4, pp. 223-229
-
Mobile applications for the management of chronic physical conditions: a systematic review
Internal Medicine Journal, Vol. 52, Núm. 1, pp. 21-29
2021
-
Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking
European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e22
-
Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder
Revista de Psiquiatria y Salud Mental
2020
-
Second Generation Antipsychotics Monotherapy as Maintenance Treatment for Bipolar Disorder: a Systematic Review of Long-Term Studies
Psychiatric Quarterly, Vol. 91, Núm. 4, pp. 1047-1060
2019
-
"readiness to Change" Predicts Efficacy of Reduction among Smokers with Severe Mental Illness
European Addiction Research, Vol. 25, Núm. 5, pp. 256-262
-
Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105
-
Prepare the smoking cessation in severe mental illness: Early diagnosis and prevention opportunities
Revista de Psiquiatria y Salud Mental
-
Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk - TIMER -): Study protocol for a randomized controlled trial
Trials, Vol. 20, Núm. 1
2016
-
La evaluacion de factores de riesgo y el asesoramiento durante 12 meses reduce el riesgo metabolico y cardiovascular en pacientes con trastornos del espectro esquizofrenico con sobrepeso u obesidad: Estudio CRESSOB
Actas Espanolas de Psiquiatria, Vol. 44, Núm. 1, pp. 20-29
-
Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder
European Neuropsychopharmacology, Vol. 26, Núm. 10, pp. 1562-1578
2014
-
Prevalence of Metabolic Syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB study
Actas Espanolas de Psiquiatria, Vol. 42, Núm. 1, pp. 9-17